BACKGROUND: Peripheral blood CD4(+) and CD8(+) T-cell subsets lacking surface CD28 have been suggested to predispose patients to immune-mediated disorders. MATERIALS AND METHODS: To determine the role of CD28(-) T-cell subset in Graves' disease (GD), we characterized peripheral blood CD4(+)CD28(-) and CD8(+)CD28(-) T cell from early onset GD patients. RESULTS AND DISCUSSION: GD patients had significantly higher percentages of CD4(+)CD28(-) and CD8(+)CD28(-) T cells than did healthy donors. Both CD28(-) T cells expressed mostly CD45RO, suggesting that they are activated and/or are memory T cells. GD patient-derived CD4(+)CD28(-) and CD8(+)CD28(-) T cells produced more intracellular IFN-gamma than their counterparts from healthy donors. Furthermore, CD4(+)CD28(-) and CD8(+)CD28(-) T cells from GD patients with Graves' ophthalmopathy (GO) secreted higher level of intracellular IFN-gamma than those CD28(-) T cells from GD patients without GO. Retrospective analysis showed that the increased levels of CD4(+)CD28(-) T cells and their IFN-gamma-producing subgroups were positively correlated to the serum anti-thyrotropin receptor (TSHR) autoantibodies (TRAb). Our observations suggest that increased IFN-gamma-producing CD28(-) T cells in GD patients may play an important role in the pathogenesis of GD.
BACKGROUND: Peripheral blood CD4(+) and CD8(+) T-cell subsets lacking surface CD28 have been suggested to predispose patients to immune-mediated disorders. MATERIALS AND METHODS: To determine the role of CD28(-) T-cell subset in Graves' disease (GD), we characterized peripheral blood CD4(+)CD28(-) and CD8(+)CD28(-) T cell from early onset GDpatients. RESULTS AND DISCUSSION: GDpatients had significantly higher percentages of CD4(+)CD28(-) and CD8(+)CD28(-) T cells than did healthy donors. Both CD28(-) T cells expressed mostly CD45RO, suggesting that they are activated and/or are memory T cells. GDpatient-derived CD4(+)CD28(-) and CD8(+)CD28(-) T cells produced more intracellular IFN-gamma than their counterparts from healthy donors. Furthermore, CD4(+)CD28(-) and CD8(+)CD28(-) T cells from GDpatients with Graves' ophthalmopathy (GO) secreted higher level of intracellular IFN-gamma than those CD28(-) T cells from GDpatients without GO. Retrospective analysis showed that the increased levels of CD4(+)CD28(-) T cells and their IFN-gamma-producing subgroups were positively correlated to the serum anti-thyrotropin receptor (TSHR) autoantibodies (TRAb). Our observations suggest that increased IFN-gamma-producing CD28(-) T cells in GDpatients may play an important role in the pathogenesis of GD.
Authors: N Matsuoka; K Eguchi; A Kawakami; M Tsuboi; H Nakamura; H Kimura; N Ishikawa; K Ito; S Nagataki Journal: J Clin Endocrinol Metab Date: 1996-11 Impact factor: 5.958
Authors: Ester M M van Leeuwen; Ester B M Remmerswaal; Mireille T M Vossen; Ajda T Rowshani; Pauline M E Wertheim-van Dillen; René A W van Lier; Ineke J M ten Berge Journal: J Immunol Date: 2004-08-01 Impact factor: 5.422
Authors: Christina Duftner; Christian Goldberger; Albrecht Falkenbach; Reinhard Würzner; Barbara Falkensammer; Karl P Pfeiffer; Elisabeth Maerker-Hermann; Michael Schirmer Journal: Arthritis Res Ther Date: 2003-07-16 Impact factor: 5.156
Authors: A U Engela; C C Baan; N H R Litjens; M Franquesa; M G H Betjes; W Weimar; M J Hoogduijn Journal: Clin Exp Immunol Date: 2013-12 Impact factor: 4.330
Authors: Gang Li; Adriana T Larregina; Robyn T Domsic; Donna B Stolz; Thomas A Medsger; Robert Lafyatis; Patrizia Fuschiotti Journal: J Invest Dermatol Date: 2016-12-22 Impact factor: 8.551
Authors: Ania Skowera; Kristin Ladell; David A Price; Mark Peakman; James E McLaren; Garry Dolton; Katherine K Matthews; Emma Gostick; Deborah Kronenberg-Versteeg; Martin Eichmann; Robin R Knight; Susanne Heck; Jake Powrie; Polly J Bingley; Colin M Dayan; John J Miles; Andrew K Sewell Journal: Diabetes Date: 2014-09-23 Impact factor: 9.461
Authors: James E Turner; John P Campbell; Kate M Edwards; Lauren J Howarth; Graham Pawelec; Sarah Aldred; Paul Moss; Mark T Drayson; Victoria E Burns; Jos A Bosch Journal: Age (Dordr) Date: 2013-07-12